Sinopharm
1099.HK
#2279
Rank
ยฃ6.09 B
Marketcap
ยฃ1.95
Share price
-1.51%
Change (1 day)
-3.19%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2024: ยฃ58.52 Billion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is ยฃ58.52 Billion. In 2024 the company made a revenue of ยฃ58.52 Billion a decrease over the revenue in the year 2023 that were of ยฃ61.67 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2024

Annual revenue

Year Revenue Change
2024ยฃ58.52 B-5.1%
2023ยฃ61.67 B5.42%
2022ยฃ58.49 B-2.1%
2021ยฃ59.75 B16.85%
2020ยฃ51.13 B14.95%
2019ยฃ44.48 B21.52%
2018ยฃ36.60 B5.93%
2017ยฃ34.55 B27.22%
2016ยฃ27.16 B5.37%
2015ยฃ25.77 B9.14%
2014ยฃ23.61 B17.22%
2013ยฃ20.14 B25.94%
2012ยฃ15.99 B34.61%
2011ยฃ11.88 B55.34%
2010ยฃ7.65 B35.79%
2009ยฃ5.63 B37.56%
2008ยฃ4.09 B31.43%
2007ยฃ3.11 B40.26%
2006ยฃ2.22 B